Adults and children of 12 years old or older weighing more than 40 kilogrammes with mild to moderate symptoms and a high risk of developing a severe coronavirus case due to underlying conditions will be treated with the drug.
South Korea has approved the emergency usage of Pfizer’s antiviral pills against COVID-19, the Ministry of Food and Drug Safety said Monday (Dec 27).
South Korea reinstated strict distancing restrictions this week after easing them in November, following a sequence of daily records of new infections and dangerous cases that strained medical systems, despite the vaccination rate with over 92 per cent for individuals aged 18 and older.
Source - The Times of Israel
The Pfizer-developed oral antiviral treatment called Paxlovid is “expected to help prevent serious deterioration of patients admitted to residential treatment centres or being treated at home" by broadening coronavirus treatment options beyond the injections now used in the field, drug safety minister Kim Gang-lip said.
Adults and children 12 years old or older weighing more than 40 kilogrammes with mild to moderate symptoms and a high risk of developing a severe coronavirus case due to underlying conditions will be treated with the drug.
Another oral coronavirus therapy, molnupiravir, produced by Merck and marketed outside the United States and Canada, is known as MSD. It was approved for emergency use earlier this month, but Kim said the ministry is currently studying it due to a lack of effectiveness data.
Source – Channel News Asia
